As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

Abolis Biotechnologies

5, rue Henri Desbruères – Building 6
91030 EVRY – France
Phone: +33 (0)1 86 28 02 10

Web Site >
ABOLIS - entreprise génopolitaine ABOLIS - entreprise génopolitaine

Lauréat du Concours Genopole

#Industrial Biotech

  • Synthetic biology
  • Metabolic engineering
  • Bioproduction
  • Bio-based molecules
  • Bioeconomy
  • Sustainable development


Field of Activity

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.


Abolis fuses recent advances in biology, bioinformatics, genetics and robotics to reprogram microorganisms for the production of molecules or proteins of interest. By modifying the metabolic pathways of life, the company’s technology creates industrial microbial strains capable of producing molecules of interest via fermentation.

The core concept guiding Abolis is to seek inspiration in and improve upon what nature has been doing for eons: biosynthesis.


With its synthetic biology platform, Abolis reliably provides businesses with the existing or novel molecules they need while maintaining sustainability (bio-based and/or biodegradable materials) and significantly reducing the environmental impact of molecular production.

Abolis accompanies its clients from the project study phase, through the securing of intellectual property and on to industrialization start-up


Abolis works with a number of major groups in the cosmetics, pharmaceuticals and nutrition sectors.
The company was selected within the France Relance 2021 project.
As of year-end 2021, Abolis employs more than 40 people.
The first applications resulting from Abolis’ technology will reach the market in 2024.

Collaborations sought

Abolis pursues its own research program.

In parallel, the company establishes industrial partnerships to:

  • biosource the production of its clients’ molecules;
  • secure the supply of raw materials for them by relocalizing production;
  • and furnish them with rare and/or complex compounds.
  • Further Information


    Europe counts few actors in metabolic engineering; the technology provided by Abolis gives its clients a head start for their CSR strategies.

Companies Directory

#Industrial Biotech

In the same field

The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

STH Biotech - Genopole's company

STH Biotech

STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.

Synovance - entreprise généopolitaine


Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks


Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Yposkesi - Genopole's Company


YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Watchfrog Laboratory - Genopole's company


WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Pharming - Genopole's company - Logo 2021


Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Global Bioenergies - entreprise génopolitaine - logo 2022

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

View all >
With the support from
Région île de France